Zyprexa News and Research

RSS
Zyprexa is a drug used to treat certain mental disorders. It is also being studied in the treatment of nausea and vomiting caused by some cancer treatments. It is a type of antipsychotic and a type of monoamine antagonist. Also called olanzapine and Zyprexa Zydis.
Freedland Russo announces $520M settlement over Seroquel marketing practice lawsuit against AstraZeneca

Freedland Russo announces $520M settlement over Seroquel marketing practice lawsuit against AstraZeneca

Drugmakers raised prices last year in anticipation of new health law, Eli Lilly reports financial hit

Drugmakers raised prices last year in anticipation of new health law, Eli Lilly reports financial hit

Investigators tout fraud convictions in California, Florida and New York

Investigators tout fraud convictions in California, Florida and New York

Decrease in manic symptoms severity influences prescribing decisions for bipolar mania

Decrease in manic symptoms severity influences prescribing decisions for bipolar mania

Prescription drug spending up in 2009

Prescription drug spending up in 2009

Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain

Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

State policy developments: Iowa seeks to extend birth control coverage; Minn. eyes more health care for poor; Miss. drug settlement

State policy developments: Iowa seeks to extend birth control coverage; Minn. eyes more health care for poor; Miss. drug settlement

GAO: Some meds had 'extraordinary' price hikes over past eight years

GAO: Some meds had 'extraordinary' price hikes over past eight years

ZYPREXA RELPREVV approved by FDA

ZYPREXA RELPREVV approved by FDA

Eli Lilly provides financial guidance for 2010

Eli Lilly provides financial guidance for 2010

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2B

Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2B

Antipsychotic medications increase the levels of inflammation markers, find researchers

Antipsychotic medications increase the levels of inflammation markers, find researchers

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Sheller, P.C helps to settle the largest whistleblower complaint

Sheller, P.C helps to settle the largest whistleblower complaint

Pfizer pleads guilty of defrauding Medicare, Medicaid and other government-funded health care programs

Pfizer pleads guilty of defrauding Medicare, Medicaid and other government-funded health care programs

St. Petersburg Times examines decline in antipsychotic drug prescriptions for Florida children

St. Petersburg Times examines decline in antipsychotic drug prescriptions for Florida children

Add-on treatment may reduce treatment-associated weight gain caused by antipsychotic treatments

Add-on treatment may reduce treatment-associated weight gain caused by antipsychotic treatments

FDA approves Symbyax for treatment-resistant depression

FDA approves Symbyax for treatment-resistant depression